Skip to main content
Year archive

Genscript Biotech Corporation — 2021 filings

All 95 regulatory filings released by Genscript Biotech Corporation (1548) in 2021, sourced directly from the official regulator.

95 Filings
2021 Period
2021 filings (95)
Filing Released Lang
COMPLETION OF THE(1) FOLLOW-ON PUBLIC OFFERING BY LEGEND BIOTECH CORPORATION, AND (2) DISCLOSEABLE CONNECTED TRANSACTION IN RELATION TO THE PURCHASE BY THE COMPANY IN THE FOLLOW-ON PUBLIC OFFERING
Regulatory Filings
2021-12-20 English
(1) UPDATE ON FOLLOW-ON PUBLIC OFFERING OF LEGEND BIOTECH CORPORATION (2) OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2021-12-19 English
(1) UPDATE ON FOLLOW-ON PUBLIC OFFERING BY LEGEND BIOTECH CORPORATION (2) DISCLOSEABLE CONNECTED TRANSACTION IN RELATION TO THE PURCHASE BY THE COMPANY IN THE FOLLOW-ON PUBLIC OFFERING (3) OVERSEAS RE
Regulatory Filings
2021-12-17 English
OVERSEAS REGULATORY ANNOUNCEMENT (1) FOLLOW-ON PUBLIC OFFERING BY LEGEND BIOTECH CORPORATION, AND (2) FINANCIAL RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 OF LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-12-15 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-12-13 English
Grant of Restricted Shares
Regulatory Filings
2021-12-10 English
Next Day Disclosure Return
Regulatory Filings
2021-12-10 English
Next Day Disclosure Return
Regulatory Filings
2021-12-10 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-12-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-06 English
OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2021 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-11-16 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings
2021-11-03 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-11-01 English
VOLUNTARY ANNOUNCEMENT: SERVICE AGREEMENT WITH ABOGENBIO AND WALVAX
Regulatory Filings
2021-10-22 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-10-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings
2021-10-07 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-09-23 English
LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION OF 2021 INTERIM REPORT
Regulatory Filings
2021-09-22 English
LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM - NOTICE OF PUBLICATION OF 2021 INTERIM REPORT
Regulatory Filings
2021-09-22 English
INTERIM REPORT 2021
Regulatory Filings
2021-09-22 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-09-13 English
COMPLETION OF DISCLOSEABLE TRANSACTION IN RELATION TO THE DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN
Regulatory Filings
2021-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Regulatory Filings
2021-09-03 English
Grant of Restricted Shares
Regulatory Filings
2021-08-27 English
Next Day Disclosure Return
Regulatory Filings
2021-08-24 English
ADOPTION OF RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2021-08-24 English
ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2021
Regulatory Filings
2021-08-23 English
OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-08-23 English
DISCLOSEABLE TRANSACTIONS: DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN
Regulatory Filings
2021-08-19 English
DATE OF BOARD MEETING
Regulatory Filings
2021-08-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-05 English
Next Day Disclosure Return
Regulatory Filings
2021-07-19 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION RESALE REGISTRATION STATEMENT ON FORM F-3 DECLARED EFFECTIVE
Regulatory Filings
2021-07-15 English
Next Day Disclosure Return
Regulatory Filings
2021-07-14 English
Next Day Disclosure Return
Regulatory Filings
2021-07-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Regulatory Filings
2021-07-06 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION FILED A RESALE REGISTRATION STATEMENT ON FORM F-3
Regulatory Filings
2021-07-02 English
Next Day Disclosure Return
Regulatory Filings
2021-07-02 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH CORPORATION FILED A SHELF REGISTRATION STATEMENT ON FORM F-3
Regulatory Filings
2021-07-02 English
Next Day Disclosure Return
Regulatory Filings
2021-06-24 English
Next Day Disclosure Return
Regulatory Filings
2021-06-23 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-06-22 English
Next Day Disclosure Return
Regulatory Filings
2021-06-21 English
Next Day Disclosure Return
Regulatory Filings
2021-06-16 English
INSIDE INFORMATION: COMPLETION OF DISPOSAL OF SHARES BY A CONTROLLING SHAREHOLDER
Regulatory Filings
2021-06-11 English
Next Day Disclosure Return
Regulatory Filings
2021-06-10 English
Completion of Issue of New Shares Under General Mandate
Regulatory Filings
2021-06-10 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
Regulatory Filings
2021-06-10 English
VOLUNTARY ANNOUNCEMENT-RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-06-09 English
SUPPLEMENTAL ANNOUNCEMENT
Regulatory Filings
2021-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Regulatory Filings
2021-06-04 English
GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARES
Regulatory Filings
2021-06-01 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 MAY 2021
Regulatory Filings
2021-05-28 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-05-28 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-05-27 English
UPDATE ON THE INVESTIGATION
Regulatory Filings
2021-05-25 English
COMPLETION OF DISCLOSEABLE TRANSACTION IN RELATION TO THE PURCHASE OF SHARES AND DEEMED DISPOSAL OF EQUITY INTEREST IN LEGEND BIOTECH IN RELATION TO THE PURCHASE
Regulatory Filings
2021-05-23 English
INSIDER INFORMATION - ACHIEVING MAJOR MILESTONES IN THE COLLABORATION WITH JANSSEN BIOTECH, INC.
Regulatory Filings
2021-05-21 English
OVERSEAS REGULATORY ANNOUNCEMENT: UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2021 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-05-18 English
CLARIFICATION ANNOUNCEMENT
Regulatory Filings
2021-05-14 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings
2021-05-14 English
INSIDE INFORMATION: DISPOSAL OF SHARES BY A CONTROLLING SHAREHOLDER
Regulatory Filings
2021-05-14 English
ISSUE OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2021-05-14 English
DISCLOSEABLE TRANSACTIONS: (1) BINDING TERM SHEET IN RELATION TO THE PROPOSED FINANCING OF PROBIO CAYMAN AND THE DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN IN RELATION TO THE SERIES A FINANCI
Regulatory Filings
2021-05-14 English
TRADING HALT
Regulatory Filings
2021-05-14 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings
2021-05-14 English
OVERSEAS REGULATORY ANNOUNCEMENT: THE ENTRY INTO A SUBSCRIPTION AGREEMENT FOR SALE OF ORDINARY SHARES AND WARRANT BY LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-05-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Regulatory Filings
2021-05-06 English
VOLUNTARY ANNOUNCEMENT-RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-04-30 English
LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION OF ANNUAL REPORT
Regulatory Filings
2021-04-19 English
LETTER TO REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION OF ANNUAL REPORT
Regulatory Filings
2021-04-19 English
FORM OF PROXY FOR 2021 ANNUAL GENERAL MEETING
Regulatory Filings
2021-04-16 English
PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2021-04-16 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2021-04-16 English
ANNUAL REPORT 2020
Regulatory Filings
2021-04-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Regulatory Filings
2021-04-08 English
OVERSEAS REGULATORY ANNOUNCEMENT ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2020 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-04-06 English
GRANT OF SHARE OPTIONS AND RESTRICTED SHARES
Regulatory Filings
2021-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
Regulatory Filings
2021-03-30 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings
2021-03-26 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
Regulatory Filings
2021-03-26 English
OVERSEAS REGULATORY ANNOUNCEMENT FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED 31 DECEMBER 2020 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-03-18 English
Date of Board Meeting
Regulatory Filings
2021-03-11 English
OVERSEAS REGULATORY ANNOUNCEMENT LEGEND BIOTECH ANNOUNCES EARNINGS CONFERENCE CALL
Regulatory Filings
2021-03-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Regulatory Filings
2021-03-02 English
PROFIT WARNING
Regulatory Filings
2021-02-19 English
OVERSEAS REGULATORY ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2021-02-19 English
UPDATE ON THE INVESTIGATION
Regulatory Filings
2021-02-09 English
VOLUNTARY ANNOUNCEMENT - Received FDA Emergency Use Authorization for Use of cPass SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening
Regulatory Filings
2021-02-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Regulatory Filings
2021-02-03 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-02-01 English
SUPPLEMENTAL ANNOUNCEMENT
Regulatory Filings
2021-01-13 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2021-01-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Regulatory Filings
2021-01-06 English